Source: United States Senator Kevin Cramer (R-ND)
WASHINGTON – U.S. Senator Kevin Cramer (R-ND) joined Senator Marco Rubio (R-FL) in introducing the Treatment Restoration for Emergency Antibody Therapeutics (TREAT) Act, a bill to prohibit the U.S. Department of Health and Human Services (HHS) from implementing policies that restrict hospitals and other appropriate health care facilities from ordering and receiving COVID-19 monoclonal antibody (mAb) treatments directly from manufacturers and distributors.
“The Biden Administration is changing how COVID-19 antibody treatments are distributed to states in a way that does not reflect actual need across the country,” said Senator Cramer. “Our bill would prohibit the implementation of these policies that would restrict hospitals and other providers from receiving life-saving treatments where the need is greatest, regardless of partisan politics.”
This legislation would nullify the Biden Administration’s recent policy requiring hospitals and other facilities to work through states to receive mAb supplies as well as cease the Administration’s ability to throttle the state’s supply of this life-saving treatment.
Senators Cramer and Rubio are joined on the bill by Senators Rick Scott (R-FL), Roger Marshall (R-KS), Marsha Blackburn (R-TN), Mike Braun (R-IN), and Tommy Tuberville (R-AL).